MBBS , MD - General Medicine
Endocrinologist , Internal Medicine , Diabetologist
Dr. Gupta has authored and co authored various research articles and papers with reputed publishing houses. He was associated as a Co-investigator in various researches in the field of medical sciences. With his 20 years of vast experience he has expertise in Diabetes, Thyroid disease and Male Sexual problems. His major areas of interest are Type 1 Diabetes, Insulin therapy, diabetic foot, male sexual dysfunction and hormonal disorders. Formerly, Dr. Gupta has served as a Consultant with various multi specialty hospitals like Fortis Flt Lt Rajan Dhall Hospital, Apollo Clinic, Escorts Heart Institute and All India Institute of Medical Sciences, Delhi. Presently, he is serving as a Consultant and Additional Director at Fortis C-DOC Hospital. Dr. Ritesh Gupta is a well known media personality and has delivered several talks and lectures at various academic and public forums.
Services: Type 1 Diabetes Treatment , Thyroid Disorder Treatment , Diabetic foot , Insulin Therapy , Male Sexual Dysfunction & Hormonal Disorder
B-16, Chirag Enclave Opposite Devika Tower And Nehru Place
Monday
Tuesday
Wednesday
Thursday
Friday
Saturday
Sunday
10:00 - 14:00
17:00 - 19:00
Fees: ₹ 1,200.00
MBBS
All India Institute of Medical Sciences, New Delhi (1994)
MD - General Medicine
All India Institute of Medical Sciences, New Delhi (1998)
13241 (1995)
Medical Council of India (MCI)
Handa R, Gupta R, Wig N, Agarwal P, Wali JP. Microfilariae of Wuchereria bancrofti in Ascitic Fluid. Indian J Med Sci (1996)
Gupta R, Prasad HK, Nagarkar KM, Dey AB. Preliminary study on circulating serum levels of tumor necrosis factor-Alpha in patients of tuberculosis. Indian J Clin Biochem (2000)
Misra A, Chowbey P, Makkar BM, Vikram NK, Wasir JS, Chadha D, Joshi SR, Sadikot S, Gupta R, Gulati S, Munjal YP; Consensus Group. Consensus Statement for Diagnosis of Obesity, Abdominal Obesity and the Metabolic Syndrome for Asian India
Gupta R, Misra A. Screening For And Prevention Of Diabetes In India: Need For Simple And Innovative Strategies. Diabetes Technol Ther
Subramanian A, Nigam P, Misra A, Pandey Rn, Mathur M, Gupta R, Madhusudan S. Severe Vitamin D Deficiency In Patients With Type 2 Diabetes In North India
Co-investigator In The Trial Titled Phase 2, 12 Week Randomized, Double Blind, Parallel Group Placebo-controlled Study To Evaluate Safety, Tolerability, And Efficacy Of Grc 8200, A New Oral Dpp-iv Inhibitor, In Patients With Type 2 Diabe
Co-investigator In The Trial Titled Multicenter, Randomized, Double Blind, Placebo-controlled Clinical Trial To Evaluate The Effect Of 52 Weeks Treatment With Vildagliptin On Left Ventricular Function In Patients With Type 2 Diabetes
Co-investigator In The Trial Titled Randomized, Double-blind, Placebo- And Sitagliptin-controlled, Multi-center Study To Evaluate Safety And Efficacy Of Dutogliptin In Type 2 Diabetes Mellitus Subjects With Moderate And Severe Renal Impai
Co-investigator In The Trial Titled 12- Week Multicenter, Randomized, Double Blind, Placebo-controlled Parallel Group Adaptive Design Study To Evaluate The Efficacy On Blood Glucose Control And Safety Of Five Doses Of Lcq
Co-investigator In The Trial Titled Multicentre, Randomized, Double-blind, Placebo-controlled Phase Iv Trial To Evaluate The Effect Of Saxagliptin On The Incidence Of Cardiovascular Death, Myocardial Infarction Or Ischemic Stroke In Patie
Fortis C-DOC Centre of Excellence for Diabetes, Metabolic Diseases and Endocrinology
Additional Director at Fortis C-DOC
Fortis C-DOC Centre of Excellence for Diabetes, Metabolic Diseases and Endocrinology
Head Clinical Operations and Senior Consultant
Fortis Flt Lt Rajan Dhall Hospital, Vasant Kunj
Consultant in the Department of Diabetes and Metabolic Disease
an initiative of Apollo Health and Lifestyle Limited
Consultant in Internal Medicine at Apollo Clinic
Escorts Heart Institute and Research Centre
Senior Resident in the Department of Cardiology and as Internist
All India Institute of Medical Sciences
Senior Resident (Registrar) in the Department of Medicine
MBBS
All India Institute of Medical Sciences, New Delhi (1994)
MD - General Medicine
All India Institute of Medical Sciences, New Delhi (1998)
Medical Council of India (MCI)
Handa R, Gupta R, Wig N, Agarwal P, Wali JP. Microfilariae of Wuchereria bancrofti in Ascitic Fluid. Indian J Med Sci (1996)
Gupta R, Prasad HK, Nagarkar KM, Dey AB. Preliminary study on circulating serum levels of tumor necrosis factor-Alpha in patients of tuberculosis. Indian J Clin Biochem (2000)
Misra A, Chowbey P, Makkar BM, Vikram NK, Wasir JS, Chadha D, Joshi SR, Sadikot S, Gupta R, Gulati S, Munjal YP; Consensus Group. Consensus Statement for Diagnosis of Obesity, Abdominal Obesity and the Metabolic Syndrome for Asian India
Gupta R, Misra A. Screening For And Prevention Of Diabetes In India: Need For Simple And Innovative Strategies. Diabetes Technol Ther
Subramanian A, Nigam P, Misra A, Pandey Rn, Mathur M, Gupta R, Madhusudan S. Severe Vitamin D Deficiency In Patients With Type 2 Diabetes In North India
Co-investigator In The Trial Titled Phase 2, 12 Week Randomized, Double Blind, Parallel Group Placebo-controlled Study To Evaluate Safety, Tolerability, And Efficacy Of Grc 8200, A New Oral Dpp-iv Inhibitor, In Patients With Type 2 Diabe
Co-investigator In The Trial Titled Multicenter, Randomized, Double Blind, Placebo-controlled Clinical Trial To Evaluate The Effect Of 52 Weeks Treatment With Vildagliptin On Left Ventricular Function In Patients With Type 2 Diabetes
Co-investigator In The Trial Titled Randomized, Double-blind, Placebo- And Sitagliptin-controlled, Multi-center Study To Evaluate Safety And Efficacy Of Dutogliptin In Type 2 Diabetes Mellitus Subjects With Moderate And Severe Renal Impai
Co-investigator In The Trial Titled 12- Week Multicenter, Randomized, Double Blind, Placebo-controlled Parallel Group Adaptive Design Study To Evaluate The Efficacy On Blood Glucose Control And Safety Of Five Doses Of Lcq
Co-investigator In The Trial Titled Multicentre, Randomized, Double-blind, Placebo-controlled Phase Iv Trial To Evaluate The Effect Of Saxagliptin On The Incidence Of Cardiovascular Death, Myocardial Infarction Or Ischemic Stroke In Patie
Fortis C-DOC Centre of Excellence for Diabetes, Metabolic Diseases and Endocrinology
Additional Director at Fortis C-DOC
Fortis C-DOC Centre of Excellence for Diabetes, Metabolic Diseases and Endocrinology
Head Clinical Operations and Senior Consultant
Fortis Flt Lt Rajan Dhall Hospital, Vasant Kunj
Consultant in the Department of Diabetes and Metabolic Disease
an initiative of Apollo Health and Lifestyle Limited
Consultant in Internal Medicine at Apollo Clinic
Escorts Heart Institute and Research Centre
Senior Resident in the Department of Cardiology and as Internist
All India Institute of Medical Sciences
Senior Resident (Registrar) in the Department of Medicine
Reviews